Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus

Diabetology and Metabolic Syndrome

Volumn 4, Issue 1, 2012, Pages

  Mori, Katsuhito ^a   Emoto, Masanori ^a   Motoyama, Koka ^a   Lee, Eiko ^a   Yamada, Shinsuke ^a   Morioka, Tomoaki ^a   Imanishi, Yasuo ^a   Shoji, Tetsuo ^a   Inaba, Masaaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Insulin resistance; Osteocalcin; Type 2 diabetes; Undercarboxylated osteocalcin

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN; INSULIN; OSTEOCALCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNDERCARBOXYLATED OSTEOCALCIN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; FEMALE; GLUCOSE INFUSION; GLUCOSE METABOLISM; GOLD STANDARD; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; STEADY STATE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84871176808     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-4-53     Document Type: Article

References (14)

1. Motyl KJ, McCabe LR, Schwartz AV: Bone and glucose metabolism: a two-way street. Arch Biochem Biophys 2010, 503:2-10.
2. Ng KW: Regulation of glucose metabolism and the skeleton. Clin Endocrinol 2011, 75:147-155.
3. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G: Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
4. Ferron M, Hinoi E, Karsenty G, Ducy P: Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci 2008, 105:5266-5270.
5. Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G: Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2012, 50:568-575.
6. Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T: Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporosis Int 2011, 22:187-194.
7. Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, Jacques PF, Booth SL: Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 2009, 90:1230-1235.
8. Iki M, Tamaki J, Fujita Y, Kouda K, Yura A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N, Kurumatani N: Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporosis Int 2012, 23:761-770.
9. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig 2010, 1:212-228.
10. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H: Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999, 22:818-822.
11. Emoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K, Tahara H, Ishimura E, Inaba M, Okuno Y, Nishizawa Y: Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 2001, 24:533-538.
12. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
13. Bullo M, Moreno-Navarrete JM, Fernandez-Real JM, Salas-Salvado J: Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and beta cell function in elderly men at high cardiovascular risk. Am J Clin Nutr 2012, 95:249-255.
14. Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev 2005, 26:439-451.